{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Schildhauer P"],"funding":["Halle Doctoral College in Medicine (HaPKoM)","Medical Faculty of Martin Luther University Halle-Wittenberg","DFG"],"pagination":["1219"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10177211"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12(9)"],"pubmed_abstract":["Glioblastoma (GBM) is a highly aggressive and invasive brain tumor with a poor prognosis despite extensive treatment. The switch to aerobic glycolysis, known as the Warburg effect, in cancer cells leads to an increased production of methylglyoxal (MGO), a potent glycation agent with pro-tumorigenic characteristics. MGO non-enzymatically reacts with proteins, DNA, and lipids, leading to alterations in the signaling pathways, genomic instability, and cellular dysfunction. In this study, we investigated the impact of MGO on the LN229 and U251 (WHO grade IV, GBM) cell lines and the U343 (WHO grade III) glioma cell line, along with primary human astrocytes (hA). The results showed that increasing concentrations of MGO led to glycation, the accumulation of advanced glycation end-products, and de"],"journal":["Cells"],"pubmed_title":["Glycation Leads to Increased Invasion of Glioblastoma Cells."],"pmcid":["PMC10177211"],"funding_grant_id":["RTG 2155"],"pubmed_authors":["Strauss C","Selke P","Scheer M","Schildhauer P","Leisz S","Scheller C","Horstkorte R"],"additional_accession":[]},"is_claimable":false,"name":"Glycation Leads to Increased Invasion of Glioblastoma Cells.","description":"Glioblastoma (GBM) is a highly aggressive and invasive brain tumor with a poor prognosis despite extensive treatment. The switch to aerobic glycolysis, known as the Warburg effect, in cancer cells leads to an increased production of methylglyoxal (MGO), a potent glycation agent with pro-tumorigenic characteristics. MGO non-enzymatically reacts with proteins, DNA, and lipids, leading to alterations in the signaling pathways, genomic instability, and cellular dysfunction. In this study, we investigated the impact of MGO on the LN229 and U251 (WHO grade IV, GBM) cell lines and the U343 (WHO grade III) glioma cell line, along with primary human astrocytes (hA). The results showed that increasing concentrations of MGO led to glycation, the accumulation of advanced glycation end-products, and de","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Apr","modification":"2026-04-08T12:26:44.414Z","creation":"2025-04-05T21:08:05.196Z"},"accession":"S-EPMC10177211","cross_references":{"pubmed":["37174618"],"doi":["10.3390/cells12091219"]}}